{"id":83038,"date":"2024-06-25T09:41:40","date_gmt":"2024-06-25T09:41:40","guid":{"rendered":"https:\/\/rdnews.al\/?p=83038"},"modified":"2024-06-25T09:51:22","modified_gmt":"2024-06-25T09:51:22","slug":"skeme-abuzimi-masive-si-e-ndihmon-fondi-i-sigurimeve-mafian-e-ilaceve","status":"publish","type":"post","link":"https:\/\/rdnews.al\/index.php\/2024\/06\/25\/skeme-abuzimi-masive-si-e-ndihmon-fondi-i-sigurimeve-mafian-e-ilaceve\/","title":{"rendered":"Skem\u00eb abuzimi masive\/ Si e ndihmoi Fondi i Sigurimeve mafian e ila\u00e7eve"},"content":{"rendered":"

Nj\u00eb audit verifikues i Kontrollit t\u00eb Lart\u00eb t\u00eb Shtetit mbi shkeljet e konstatuara m\u00eb her\u00ebt t\u00eb Fondit t\u00eb Detyruesh\u00ebm t\u00eb Kujdesit Sh\u00ebndet\u00ebsor (FSKDSH) ka zbuluar se institucioni publik vijon t\u00eb toleroj\u00eb abuzimet e depove farmaceutike me faturat e ila\u00e7eve t\u00eb rimbursueshme.<\/strong><\/em><\/p>\n

Rreth nj\u00eb vit m\u00eb par\u00eb, KLSH konstatoi se disa depo kryesore farmaceutike, p\u00ebrfshir\u00eb \u201cCFO Pharma\u201d e Nadir \u00c7aushollit apo \u201cMegapharma\u201d e Rasim Hamzarajt, kishin probleme t\u00eb theksuar me dokumentacionin justifikues t\u00eb shitjes s\u00eb medikamenteve q\u00eb jan\u00eb n\u00eb list\u00ebn e rimbureshme.<\/strong><\/em><\/p>\n

KLSH u rikthye n\u00eb fillim t\u00eb vitit 2024, p\u00ebr t\u00eb konstatuar hapat e nd\u00ebrmarr\u00eb nga Fondi i Kujdesit Sh\u00ebndet\u00ebsor p\u00ebr t\u00eb riparuar d\u00ebmet financiare.<\/strong><\/em><\/p>\n

N\u00eb nj\u00eb raport t\u00eb hartuar s\u00eb fundmi, dhe i siguruar nga portal informativ \u201cPrapaskena\u201d, tregon se grupet e kontrollit t\u00eb Fondit t\u00eb Kujdesit Sh\u00ebndet\u00ebsor kan\u00eb vijuar me pasivitetin e tyre, duke kryer kontrolle fiktive ose nuk kan\u00eb kryer procedura verifikuese p\u00ebr muaj t\u00eb t\u00ebr\u00eb.<\/strong><\/em><\/p>\n

Nj\u00eb raport i fundit (2024) i Kontrollit t\u00eb Lart\u00eb t\u00eb Shtetit konfirmon edhe nj\u00eb her\u00eb se Fondi i Sigurimit t\u00eb Detyruesh\u00ebm t\u00eb Kujdesit Sh\u00ebndet\u00ebsor mbetet nj\u00eb nga organet publike m\u00eb t\u00eb korruptuara si dhe nj\u00eb nga gjenerator\u00ebt m\u00eb t\u00eb palodhur t\u00eb skemave t\u00eb mashtrimit e vjedhjeve n\u00eb Shqip\u00ebri, p\u00ebrfitimit me barna t\u00eb skaduara, receta fiktive dhe skema t\u00eb tjera zhvatje.<\/p>\n

KLSH konstaton vijimin e skem\u00ebs s\u00eb mashtrimit me barnat e rimbursueshme, p\u00ebrmes recetave fiktive, si dhe daljen jasht\u00eb kontrollit t\u00eb FSDKSH t\u00eb depove farmaceutike, t\u00eb cilat jan\u00eb p\u00ebrfshir\u00eb n\u00eb abuzime me pasoja t\u00eb r\u00ebnda jo vet\u00ebm n\u00eb buxhetin e shtetit, por pik\u00ebs\u00ebpari n\u00eb sh\u00ebndetin e qytetar\u00ebve.<\/p>\n

Mafia e ila\u00e7eve funksion si kartel; Fondi, depot farmaceutike q\u00eb lejohen nga fondi t\u00eb b\u00ebjn\u00eb k\u00ebrdin\u00eb, rrjet farmacish dhe rrjet mjek\u00ebsh. Parat\u00eb ndahen sipas roleve.<\/p>\n

\u201cSi p\u00ebrfundim, nga auditimi konstatohet se nuk \u00ebsht\u00eb kryer asnj\u00eb kontroll me inventarizim n\u00eb depot farmaceutike edhe pse
\nn\u00ebp\u00ebrmjet raportit t\u00eb KLSH-s\u00eb t\u00eb vitit 2021, \u00ebsht\u00eb konstatuar se nuk \u00ebsht\u00eb ushtruar kontroll n\u00eb depo farmaceutike mbi sasit\u00eb e barnave n\u00eb mbyllje dhe n\u00eb hapje t\u00eb periudh\u00ebs s\u00eb LBR-s\u00eb sipas indeksimit, ku ka patur diferenca inventari n\u00eb shtes\u00eb n\u00eb shum\u00ebn 52 milion lek\u00eb dhe n\u00eb minus n\u00eb shum\u00ebn 207.6 milion lek\u00eb, me pasoj\u00eb efekte negative n\u00eb administrimin e fondeve n\u00ebn skem\u00ebn e kujdesit sh\u00ebndet\u00ebsor p\u00ebrsa i p\u00ebrket barnave t\u00eb rimbursueshme. Nga sa m\u00eb sip\u00ebr grupi i audituesve t\u00eb KLSH, konstaton se ky sektor ka patur nj\u00eb nivel t\u00eb ul\u00ebt t\u00eb realizimit t\u00eb kontrolleve dhe muajve inekzistent\u00eb t\u00eb aktivitetit, duke mos plot\u00ebsuar detyrat funksionale q\u00eb i ngarkohen sipas Rregullores nr. 3, dat\u00eb 22.10.2014 \u201cP\u00ebr procedur\u00ebn dhe m\u00ebnyr\u00ebn e kontrollit t\u00eb dh\u00ebn\u00ebsve t\u00eb sh\u00ebrbimit t\u00eb kontraktuara me FONDIN<\/strong><\/em>\u201c, thuhet n\u00eb raport.<\/p>\n

KLSH ka identifikuar edhe disa nga depot farmaceutike q\u00eb abuzojn\u00eb me ila\u00e7et, q\u00eb mbajn\u00eb barna t\u00eb skaduara n\u00eb kund\u00ebrshtim me rregullat, q\u00eb nuk kontrollohen nga FSDKSH, q\u00eb raportojn\u00eb t\u00eb dh\u00ebna t\u00eb rreme te FSDKSH, q\u00eb dyshohet se mund t\u00eb jen\u00eb p\u00ebrfshir\u00eb n\u00eb skemat e mashtrimit me rimbursimet.<\/p>\n

Megapharma e Rasim Hamzarajt, ila\u00e7e t\u00eb pajustifikuara n\u00eb depo dhe transaksione t\u00eb dyshimta<\/strong><\/p>\n

\"\"<\/p>\n

\u201cGrupi i audituesve t\u00eb Kontrollit t\u00eb Lart\u00eb t\u00eb Shtetit, konstaton se nga ana e grupit t\u00eb kontrollit jan\u00eb marr\u00eb n\u00eb konsiderat\u00eb transaksionet t\u00eb cilat pretendohen nga ana e subjektit \u201cMegapharma\u201d SHPK, se jan\u00eb t\u00eb anuluara, por p\u00ebr t\u00eb cilat nuk jan\u00eb vendosur n\u00eb dispozicion faturat anulluese tatimore sipas dispozitave t\u00eb legjislacionit fiskal n\u00eb fuqi, p\u00ebr t\u00eb cilat \u00ebsht\u00eb sqaruar m\u00eb lart. Nga sa m\u00eb sip\u00ebr rrjedh se n\u00eb Depon Importuese \u201cMegapharma\u201d SHPK, rezulton diferenca n\u00eb plus (gjendja fizike e barnave t\u00eb list\u00ebs \u00ebsht\u00eb m\u00eb e madhe se gjendja kontab\u00ebl) n\u011b vler\u00ebn 3,732,066 lek\u00eb, dhe nga FSDKSH nuk \u00ebsht\u00eb vendosur mas\u00eb administrative n\u00eb vler\u00ebn 7,464,132 lek\u00eb (3,732,066 lek\u00eb x 2), sipas p\u00ebrcaktimeve t\u00eb Nenit 16 t\u00eb Kontrat\u00ebs \u201cPer qarkullimin e barnave t\u00eb list\u00ebs s\u00eb barnave q\u00eb rimbursohen nga importuesit farmaceutik\u201d n\u00ebp\u00ebrmjet Fondit t\u00eb Sigurimit t\u00eb Detyruesh\u00ebm t\u00eb Kujdesit Sh\u00ebndet\u00ebsor dhe Importuesit Farmaceutik Megapharma SHPK\u201d, ku p\u011brcaktohet se: 7. \u201cKur nga verifikimi i gjendjes fizike t\u00eb barnave t\u00eb rimbursueshme tek Importuesi rezultojn\u00eb diferenca n\u00eb plus t\u00eb pajustifikuara (gjendja fizike me e madhe se gjendja kontab\u00ebl), Importuesi paguan kusht penal t\u00eb barabart\u00eb me dyfishin e tepric\u00ebs s\u00eb konstatuar\u201d.<\/em><\/p>\n

\"\"<\/p>\n

CFO Pharma, Nadir \u00c7aushollit, i arrestuar m\u00eb par\u00eb m\u00eb skema mashtrimi me vler\u00eb mbi 2 milion\u00eb euro<\/strong><\/p>\n

\u201cGrupi i kontrollit nga Fondi: Entuena, Brikena Hajdari, Dorjan Hysi, Irsa Vila, Sabri \u00c7ela, Bora Shkurta. Drejtor Kontrolli: Shpend Stojku. Drejtor i P\u00ebrgiithsh\u00ebm: Albana \u00c7ela. Nga auditimi i dokumentacionit te dosjes s\u00eb raport kontrollit t\u00eb plot\u00eb me inventarizim t\u00eb depos- importuese \u201cCFO Pharma\u201d SHPK, kan\u00eb rezultuar problematikat trajtuar si m\u00ebposht\u00eb: Sipas Raport Kontrollit nr. 6713\/5 prot., dat\u00eb 07.12.2022, jan\u00eb evidentuar diferencat e konstatuara p\u00ebr periudh\u00ebn 01.08.2021-30.04.2022\u2026. Nga ana e grupit t\u00eb kontrollit nuk \u00ebsht\u00eb vepruar konform p\u0113rcaktimeve t\u00eb pik\u0113s 4 t\u00eb nenit 16 \u201cKushti Penal\u201d t\u00eb kontrat\u00ebs s\u00eb lidhur me Depon Importuese \u201cCFO Pharma\u201d, ku p\u00ebrcaktohet qart\u00ebsisht se: \u201cKur nga kontrolli rezulton Se Importuesi ka d\u00ebrguar n\u00eb FOND informacion jo t\u00eb sakt\u00eb, ai paguan kusht penal prej 200,000 lek\u00eb\u201d. Veprimet e m\u00ebsip\u00ebrme bien n\u00eb kund\u00ebrshtim me p\u00ebrcaktimet ligjore e n\u00ebnligjore si m\u00eb posht\u00eb: Rregullore nr.2 \u201cP\u00ebr organizimin, funksionimin dhe p\u0113rshkrimet e pun\u00ebs per Drejtorin\u00eb e P\u0113rgjithshme t\u00eb Fondit\u201d\u2018; Kreu 1 \u201cDrejtor i P\u00ebrgjithsh\u00ebm\u201d, Kreu XI \u201cDrejtoria e Kontrollit \u2013 Sektori i Kontrollit t\u00eb Depove Farmaceutike\u201d; Rregullore nr.3 dat\u00eb 22.10.2014 \u201cP\u00ebr procedur\u00ebn dhe m\u00ebnyr\u00ebn e kontrollit t\u00eb dh\u00ebn\u00ebsve t\u00eb sh\u00ebrbimit t\u00eb kontraktuara me fondin\u201d, Kapitulli Ill\u201dP\u00ebr kontrollin n\u00eb depot farmaceutike t\u00eb barnave te kontraktuara nga fondi i sigurimit te detyruesh\u00ebm t\u00eb kujdesit shendetesor\u2019, Kontrata \u201cP\u00ebr qarkullimin e barnave t\u00eb list\u00ebs s\u00eb barnave q\u00eb rimbursohen nga importuesit farmaceutik\u201d n\u011bp\u00ebrmjet Fondit t\u00eb Sigurimit t\u00eb Detyruesh\u00ebm t\u00eb Kujdesit Sh\u00ebndet\u00ebsor dhe Depon Importuese \u201cCFO Pharma\u201d SHPK, neni 16, pika 4. P\u00ebr subjektin \u201cCFO Pharma\u201d Shpk, sqarojm\u00eb se diferencat n\u00eb minus t\u00eb evidentuara nga grupi i kontrolli n\u00eb raport kontrolli p\u00ebrb\u00ebjn\u00eb informacion jo t\u00eb sakt\u00eb dhe jo t\u00eb rakorduar, me informacionin e d\u00ebrguar n\u00eb fond dhe sipas sistemit e-depo, observacioni p\u00ebrmban t\u00eb nj\u00ebjtat argumente t\u00eb d\u00ebrguara n\u00eb faz\u00ebn e projekt raportit t\u00eb auditimit, pa sjell\u00eb fakte t\u00eb reja, kjo pjes\u00eb e observacionit nuk do t\u00eb merret n\u00eb konsiderat\u00eb\u201d.<\/em><\/p>\n

Rejsi Rama e Merita Sheqit ila\u00e7e t\u00eb skaduara, rrezik q\u00eb t\u2019i hedh\u00eb n\u00eb treg<\/strong><\/p>\n

\"\"<\/p>\n

\u201cNga auditimi i dokumentacionit t\u00eb dosjeve t\u00eb raport kontrolleve t\u00eb plota me inventarizim n\u00eb depot importuese dhe shp\u00ebrndar\u00ebse t\u00eb subjektit \u201cRejsi Farma\u201d SHPK, kan\u00eb rezultuar problematikat: Nga ana e grupit t\u00eb kontrollit jan\u00eb marr\u00eb n\u00eb konsiderat\u00eb lista e barnave prej 18 medikamente, n\u00eb sasin\u00eb 12,178 cop\u00eb, me vler\u00eb 41,999,556 lek\u00eb, t\u00eb cilat pretendon se u ka kaluar afati i skadenc\u00ebs edhe mbi 1 vit, p\u00ebr t\u00eb cilat \u00ebsht\u00eb mbajtur vet\u00ebm nj\u00eb proces-verbal nr. 2\/1, dat\u00eb 21.12.2022, me shkrim dore, i pa shoq\u00ebruar m\u00eb evidenca fotografike t\u00eb mjedisit t\u00eb ve\u00e7uar dhe t\u00eb barnave me mbishkrimin t\u00eb skaduara, p\u00ebr t\u00eb cilat nuk \u00ebsht\u00eb kryer procedura e rregullt p\u00ebr nxjerrjen jasht\u00eb p\u00ebrdorimit t\u00eb tyre, duke mos njoftuar Drejtorin Rajonale Tatimore p\u011brkat\u00ebse n\u00ebn juridiksionin t\u00eb cil\u00ebs i p\u00ebrket si dhe duke mos marr\u00eb miratim nga Agjencia Komb\u011btare e Barnave dhe Pajisjeve Mjek\u00ebsor\u00eb, sipas p\u00ebrcaktimeve t\u00eb legjislacionit n\u00eb fuqi p\u00ebr procedur\u00ebn n\u00eb lidhje me mallrat e skaduara konkretisht: Udh\u011bzimi nr. 6, dat\u00eb 30.01.201 5 \u201cP\u00ebr tatimin mbi vler\u00ebn e shtuar n\u00eb Republik\u00ebn e Shqip\u00ebris\u00eb\u201d, neni 58, pika 2, Udh\u00ebzimi nr. 5, dat\u00eb 30.01.2006 \u201cP\u00ebr tatimin mbi t\u00eb ardhurat\u201d, i ndryshuar, pika 3.6, germa S, Si dhe Kontrata F2021, neni 1, duke sjell\u00eb risk n\u00eb gjendjen e sakt\u00eb reale inventariale t\u00eb barnave t\u00eb rimbursueshme sipas LBR-s\u00eb dhe n\u00eb nivelin e rimbursimit t\u00eb p\u00ebrfituar nga Depos-Importuese \u201cRejsi Farma\u201d. Gjithashtu, ekziston risku i rifutjes n\u00eb qarkullim t\u00eb barnave t\u00eb skaduara me q\u00ebllim p\u011brfitimin e rimbursimin, me pasoja n\u00eb sh\u00ebndetin e pacient\u00ebve\u201d<\/em>.<\/p>\n

Delta Pharma, Eduart Curri<\/strong><\/p>\n

\"\"<\/p>\n

\u201cNga auditimi i dosjes s\u00eb kontrollit \u00ebsht\u00eb konstatuar se nga grupi i kontrollit nuk jan\u00eb mbajtur procesverbalet DU 7, DU 8 dhe DU 9, veprime t\u00eb cilat jan\u00eb n\u00eb kund\u00ebrshtim me pikat 11 dhe 12 te Kapitullit II t\u00eb \u201cP\u00ebr kontrollin n\u00eb depot farmaceutike t\u00eb barnave t\u00eb kontraktuara nga Fondi i Sigurimit t\u00eb Detyruesh\u00ebm t\u00eb Kujdesit Sh\u00ebndet\u00ebsor\u201d t\u00eb Rregullores nr. 3, dat\u00eb 22.10.2014 \u201cPer procedur\u00ebn dhe m\u00ebnyr\u00ebn e kontrollit t\u00eb dh\u00ebn\u00ebsve t\u00eb sh\u00ebrbimit t\u00eb kontraktuara me FONDIN\u201d. Sipas Memo \u201cMbi monitorimin dhe verifikimin e disponibilitetit t\u00eb barnave t\u00eb rimbursueshme n\u00eb tregun farmaceutik, muaj Mars, viti 2022\u201d nr. 1681\/1 prot., dat\u00eb 05.04.2022 t\u00eb Drejtoris\u00eb se Rimbursimit drejtuar Drejtoris\u00eb s\u00eb Kontrollit, ku jan\u00eb konstatuar mungesa t\u00eb barit \u201cMethotrexate 2.5 mg\u201d n\u00eb farmacit\u00eb e rrjetit t\u00eb hapur. Por nga ana e Drejtorit t\u00eb Kontrollit nuk \u00ebsht\u00eb p\u00ebrfshir\u00eb p\u00ebr verifikimin e disponibilitetin e tij.
\nK\u00ebto veprime jan\u00eb n\u00eb kund\u00ebrshtim me pik\u00ebn 1 t\u00eb Kapitullit Ill t\u00eb \u201cP\u00ebr kontrollin n\u00eb depot farmaceutike t\u00eb barnave t\u00eb kontraktuara nga fondi i sigurimit t\u00eb detyruesh\u00ebm t\u00eb kujdesit sh\u00ebndet\u00ebsor\u201d t\u00eb Rregullores nr. 3, dat\u00eb 22.10.2014 \u201cP\u00ebr procedur\u00ebn dhe m\u00ebnyr\u00ebn e kontrollit te dh\u00ebn\u00ebsve t\u00eb sh\u00ebrbimit t\u00eb kontraktuara me fondin\u201d.<\/em><\/p>\n

Incomed, Gentian Kreka, p\u00ebrfitues i 600 tenderave n\u00eb sh\u00ebndet\u00ebsi<\/strong><\/p>\n

\"\"<\/p>\n

\n
\n
\n

\u201cNga auditimi\u00a0dosjes s\u00eb kontrollit \u00ebsht\u00eb konstatuar se, nga grupi i kontrollit nuk jan\u00eb mbajtur procesverbalet DU 7, DU 8 dhe DU 9, veprime t\u00eb cilat jan\u00eb n\u00eb kund\u00ebrshtim me pikat 11 dhe 12 te Kapitullit Ill t \u201cP\u00ebr kontrollin n\u00eb depot farmaceutike t\u00eb barnave t\u00eb kontraktuara nga fondi i sigurimit t\u00eb detyruesh\u00ebm t\u00eb kujdesit sh\u00ebndetes or\u201d t\u00eb Rregullores nr. 3, dat\u00eb 22.10.2014 \u201cPer procedur\u00ebn dhe m\u00ebnyr\u00ebn e kontrolit t\u00eb dh\u011bn\u00ebsve t\u00eb sh\u00ebrbimit t\u00eb kontraktuara me fondin\u201d. Veprimet e m\u00ebsip\u00ebrme bien n\u00eb kund\u00ebrshtim me p\u00ebrcaktimet ligjore e n\u00ebnligjore si m\u00eb posht\u00eb: Rregullore nr. 2 \u201cP\u00ebr organizimin, funksionimin dhe p\u00ebrshkrimet e pun\u00ebs p\u00ebr Drejtorin\u00eb e P\u00ebrgjithshme t\u00eb Fondit\u201d; Kreu I \u201cDrejtor i P\u00ebrgjithsh\u00ebm\u201d, Kreu X1 \u201cDrejtoria e Kontrollit- Sektori i Kontrollit t\u00eb Depove Farmaceutike\u201d; Rregullore nr. 3, date 22. 10.2 ,2014 \u201cP\u00ebr procedur\u00ebn dhe m\u00ebnyr\u00ebn e kontrollit t\u00eb dh\u00ebn\u00ebsve t\u00eb sh\u00ebrbimit t\u00eb kontraktuara me fondin\u201d, Kapitulli Ill \u201cP\u00ebr kontrollin n\u00eb depot farmaceutike t\u00eb barnave t\u00eb kontraktuara nga Fondi i Sigurimit t\u00eb Detyruesh\u00ebm t\u00eb Kujdesit Shendet\u00ebsor\u201d pika 11 dhe 12\u2033.<\/em><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nj\u00eb audit verifikues i Kontrollit t\u00eb Lart\u00eb t\u00eb Shtetit mbi shkeljet e konstatuara m\u00eb her\u00ebt t\u00eb Fondit t\u00eb Detyruesh\u00ebm t\u00eb Kujdesit Sh\u00ebndet\u00ebsor (FSKDSH) ka zbuluar se institucioni publik vijon t\u00eb toleroj\u00eb abuzimet e depove farmaceutike me faturat e ila\u00e7eve t\u00eb rimbursueshme. Rreth nj\u00eb vit m\u00eb par\u00eb, KLSH konstatoi se disa depo kryesore farmaceutike, p\u00ebrfshir\u00eb \u201cCFO …<\/p>\n","protected":false},"author":4,"featured_media":83039,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[],"class_list":["post-83038","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-politike"],"_links":{"self":[{"href":"https:\/\/rdnews.al\/index.php\/wp-json\/wp\/v2\/posts\/83038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rdnews.al\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rdnews.al\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rdnews.al\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/rdnews.al\/index.php\/wp-json\/wp\/v2\/comments?post=83038"}],"version-history":[{"count":0,"href":"https:\/\/rdnews.al\/index.php\/wp-json\/wp\/v2\/posts\/83038\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rdnews.al\/index.php\/wp-json\/wp\/v2\/media\/83039"}],"wp:attachment":[{"href":"https:\/\/rdnews.al\/index.php\/wp-json\/wp\/v2\/media?parent=83038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rdnews.al\/index.php\/wp-json\/wp\/v2\/categories?post=83038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rdnews.al\/index.php\/wp-json\/wp\/v2\/tags?post=83038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}